financetom
Business
financetom
/
Business
/
Update: Calian Group Up 2.5% as It Signs Over $50 Million in Defense Contracts in Fiscal Q1
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: Calian Group Up 2.5% as It Signs Over $50 Million in Defense Contracts in Fiscal Q1
Feb 6, 2025 9:12 AM

11:42 AM EST, 02/06/2025 (MT Newswires) -- (Updates shares.)

Calian Group ( CLNFF ) said Thursday that it signed over $50 million in new and renewed multi-year defense contracts in its fiscal first quarter.

Of the almost 30 contracts, half will provide operational readiness training, including one for NATO's Joint Warfare Centre, Calian said.

Under the terms, Calian will serve as the prime contractor, providing the majority of JWC's critical defense training in the form of military and civilian subject matter experts.

Calian said this support will include helping ensure forces can work together efficiently in a crisis and increasing the effectiveness and readiness of NATO's multinational forces.

"The surge in global defense budgets underscores the demands of modern warfare and continued geopolitical instability," chief executive Kevin Ford said. "As we look ahead, Calian recognizes our militaries need trusted, dependable partners to deliver mission-critical solutions."

Calian shares were last seen up $1.22 to $49.51 on the Toronto Stock Exchange.

Price: 49.51, Change: +1.22, Percent Change: +2.53

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Why Sangamo Therapeutics Stock Is Soaring
Why Sangamo Therapeutics Stock Is Soaring
Aug 6, 2024
Sangamo Therapeutics, Inc. ( SGMO ) shares are trading higher Tuesday after the company announced it has entered into a license agreement with Genentech to develop intravenously administered genomic medicines for neurodegenerative diseases.  The Details: Sangamo has granted Genentech an exclusive license to its proprietary zinc finger repressors and neurotropic adeno-associated virus (AAV) capsid, STAC-BBB. Under the terms of the...
CSX Likely to See Stable H2 Amid Mixed Conditions, UBS Says
CSX Likely to See Stable H2 Amid Mixed Conditions, UBS Says
Aug 6, 2024
01:38 PM EDT, 08/06/2024 (MT Newswires) -- CSX (CSX) expects a stable second half of the year even though market conditions remain mixed, UBS said in a note emailed Tuesday. The rail freight company reported Q2 EPS of $0.49, beating estimates of $0.48, with a 2.1% volume increase and a 3.6% rise in merchandise yields. Operating expenses of $2.25 billion...
German drugstore chain shuns Teslas over Musk's support for Trump
German drugstore chain shuns Teslas over Musk's support for Trump
Aug 6, 2024
FRANKFURT, Aug 6 (Reuters) - German drugstore chain Rossmann said on Tuesday it would no longer buy Tesla cars for its corporate fleet due to CEO Elon Musk's support for U.S. Republican presidential candidate Donald Trump. The drugstore chain, which is among the largest in Europe, said its decision was with immediate effect and due to what it called an...
Update: Market Chatter: AGCO Faces Pressure For Board Shakeup From Top Shareholder
Update: Market Chatter: AGCO Faces Pressure For Board Shakeup From Top Shareholder
Aug 6, 2024
01:31 PM EDT, 08/06/2024 (MT Newswires) -- (Updates with additional details and MT Newswires' request for comment) AGCO's ( AGCO ) largest shareholder, Tractors and Farm Equipment, is seeking to replace AGCO ( AGCO ) directors through a consent solicitation process, before their terms are complete at the next annual shareholder meeting, Bloomberg reported Tuesday, citing people familiar with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved